Is Ozempic the miracle fix for Britain’s labour market woes? This morning Health Secretary Wes Streeting has announced a £280 million investment into the UK from US pharmaceutical giant Lilly, which will include the first ‘real-world trial’ to give weight-loss jabs to people out of work. The news coincides with the publication of the latest labour market overview by the Office for National Statistics, showing the number of people out of work due to long-term sickness is still at a near-record high: 2.75
Already a subscriber? Log in
Subscribe for just $2 a week
Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in